• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Fierce 50
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Fierce 50
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Biotech

hhs
Biotech

ModeX nets up to $168M in BARDA bucks to cook up new antibodies

ModeX has snagged a $168 million contract from BARDA, including $59 million upfront to finance a phase 1 trial for a novel COVID-19 antibody.
Max Bayer Sep 29, 2023 10:43am
IPO

Adlai bags $57.5M IPO to test ex-Novartis cancer drug in phase 3

Sep 29, 2023 10:00am
Emulate
Sponsored

Improving the Drug Development Process with Organ-Chips

Sep 25, 2023 8:00am
parachutes peru

Madrigal COO departs days after new CEO starts—Chutes & Ladders

Sep 29, 2023 9:30am
IPMai
Sponsored

Uncover the Rare Disease Patient Journey

Sep 25, 2023 8:00am
European Medicines Agency

PTC deepens layoffs as DMD drug faces loss of EU authorization

Sep 29, 2023 8:51am
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy